Lantern Pharma, Inc. (LTRN)
3.73
+0.14
(+3.90%)
USD |
NASDAQ |
Jun 08, 16:00
3.73
0.00 (0.00%)
After-Hours: 20:00
Lantern Pharma Market Cap : 41.98M for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Replimune Group, Inc. | 715.49M |
| Arrowhead Pharmaceuticals, Inc. | 10.38B |
| Oncolytics Biotech, Inc. | 98.13M |
| Sangamo Therapeutics, Inc. | 89.07M |
| Sarepta Therapeutics, Inc. | 1.641B |
Market Cap Related Metrics
| Price to Book Value | 12.18 |
| Price | 3.73 |
| Earnings Yield | -38.74% |